{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:09:35Z","timestamp":1794647375623,"version":"4.9.1"},"reference-count":38,"publisher":"BMJ","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"accepted":{"date-parts":[[2013,3,17]]},"published-print":{"date-parts":[[2013,6,15]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To evaluate the cost-effectiveness of diagnostic strategies for coronary heart disease (CHD) derived from the CE-MARC study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Cost-effectiveness analysis using a decision analytic model to compare eight strategies for the diagnosis of CHD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Secondary care out-patients (Cardiology Department).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients<\/jats:title>\n                  <jats:p>Patients referred to cardiologists for the further evaluation of symptoms thought to be angina pectoris.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Interventions<\/jats:title>\n                  <jats:p>Eight different strategies were considered, including different combinations of exercise treadmill testing (ETT), single-photon emission CT (SPECT), cardiovascular magnetic resonance (CMR) and coronary angiography (CA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measures<\/jats:title>\n                  <jats:p>Costs expressed as UK sterling in 2010\u20132011 prices and health outcomes in quality-adjusted life-years (QALYs). The time horizon was 50\u2005years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Based on the characteristics of patients in the CE-MARC study, only two strategies appear potentially cost-effective for diagnosis of CHD, both including CMR. The choice is between two strategies: one in which CMR follows a positive or inconclusive ETT, followed by CA if CMR is positive or inconclusive (Strategy 3 in the model); and the other where CMR is followed by CA if CMR is positive or inconclusive (Strategy 5 in the model). The more cost-effective of these two rests on the threshold cost per QALY gained below which health systems define an intervention as cost-effective. Strategy 3 appears cost-effective at the lower end of the threshold range used in the UK (\u00a320\u2005000 per QALY gained), while Strategy 5 appears cost-effective at the higher end of the threshold range (\u00a330\u2005000 per QALY). The results are robust to various sources of uncertainty although prior likelihood of CHD requiring revascularisation and the rate at which false negative patients are eventually appropriately identified do impact upon the results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The CE-MARC study showed that CMR had superior diagnostic accuracy to SPECT and concluded that CMR should be more widely used in the investigation of patients with CHD. The economic evaluation results show that using CMR is also a cost-effective strategy and supports the wider adoption of this modality.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2013-303624","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T20:18:09Z","timestamp":1366143489000},"page":"873-881","source":"Crossref","is-referenced-by-count":102,"title":["Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study"],"prefix":"10.1136","volume":"99","author":[{"given":"Simon","family":"Walker","sequence":"first","affiliation":[{"name":"Centre for Health Economics, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Girardin","sequence":"additional","affiliation":[{"name":"Centre for Health Economics, University of York, York, UK"},{"name":"Medical Direction, Geneva University Hospitals, Geneva, Switzerland"},{"name":"Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"McKenna","sequence":"additional","affiliation":[{"name":"Centre for Health Economics, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G","family":"Ball","sequence":"additional","affiliation":[{"name":"Multidisciplinary Cardiovascular Research Centre and Leeds Institute of Genetics, Health and Therapeutics, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Nixon","sequence":"additional","affiliation":[{"name":"Clinical Trials Research Unit, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Plein","sequence":"additional","affiliation":[{"name":"Multidisciplinary Cardiovascular Research Centre and Leeds Institute of Genetics, Health and Therapeutics, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P","family":"Greenwood","sequence":"additional","affiliation":[{"name":"Multidisciplinary Cardiovascular Research Centre and Leeds Institute of Genetics, Health and Therapeutics, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sculpher","sequence":"additional","affiliation":[{"name":"Centre for Health Economics, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,4,16]]},"reference":[{"key":"2025092014531186000_99.12.873.1","unstructured":"NICE. Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin. London: NICE, 2010."},{"key":"2025092014531186000_99.12.873.2","unstructured":"IMV Medical Information Division. 2003 Nuclear medicine census market summary report. Des Plaines, IL: IMV Medical Information Division, 2003."},{"key":"2025092014531186000_99.12.873.3","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.106427"},{"key":"2025092014531186000_99.12.873.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011163432003"},{"key":"2025092014531186000_99.12.873.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010866"},{"key":"2025092014531186000_99.12.873.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.10.074"},{"key":"2025092014531186000_99.12.873.7","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000047527.11221.29"},{"key":"2025092014531186000_99.12.873.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.08.056"},{"key":"2025092014531186000_99.12.873.9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq277"},{"key":"2025092014531186000_99.12.873.10","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-10-62"},{"key":"2025092014531186000_99.12.873.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61335-4"},{"key":"2025092014531186000_99.12.873.12","unstructured":"National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London, UK, 2008."},{"key":"2025092014531186000_99.12.873.13","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/circ.54.3.947585","article-title":"Letter: Grading of angina pectoris","volume":"54","author":"Campeau","year":"1976","journal-title":"Circulation"},{"key":"2025092014531186000_99.12.873.14","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.086728"},{"key":"2025092014531186000_99.12.873.15","unstructured":"Bridgewater B Keogh B Kinsman R . Sixth National Adult Cardiac Surgical Database report 2008. London: The Society for Cardiothoracic Surgery in Great Britain & Ireland, 2008."},{"key":"2025092014531186000_99.12.873.16","unstructured":"Ludman P . BCIS audit returns: adult interventional procedures: British Cardiovascular Intervention Society, Bournemouth, UK, 2009."},{"key":"2025092014531186000_99.12.873.17","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.073890"},{"key":"2025092014531186000_99.12.873.18","unstructured":"Office for National Statistics. Subtopic population estimates by age and sex: ONS, Newport, UK."},{"key":"2025092014531186000_99.12.873.19","unstructured":"Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation NRC. Health risks from exposure to low levels of ionizing radiation: BEIR VII Phase 2. Washington, DC: The National Acadamies Press, 2006."},{"key":"2025092014531186000_99.12.873.20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.191650"},{"key":"2025092014531186000_99.12.873.21","first-page":"1","article-title":"United States Life Tables, 1999","volume":"50","author":"Anderson","year":"2002","journal-title":"Natl Vital Stat Rep"},{"key":"2025092014531186000_99.12.873.22","unstructured":"Department of Health. NHS reference costs 2010\u20132011. London: Department of Health, 2011."},{"key":"2025092014531186000_99.12.873.23","unstructured":"National Institute for Health and Clinical Excellence. Chest pain of recent onset: costing report- implementing NICE guidance. London: NICE, 2011."},{"key":"2025092014531186000_99.12.873.24","unstructured":"Curtis L . Unit costs of health and social Care 2011. Canterbury: PSSRU, 2011."},{"key":"2025092014531186000_99.12.873.25","unstructured":"Rabin R Oemar M Oppe M . EQ-5D-3L user guide. Rotterdam, The Netherlands: EuroQol Group, 2011."},{"key":"2025092014531186000_99.12.873.26","unstructured":"Kind P Hardman G Macran S . UK population norms for EQ-5D. Discussion paper. York: Centre for Heath Economics, University of York, 1999."},{"key":"2025092014531186000_99.12.873.27","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-005-0309-y"},{"key":"2025092014531186000_99.12.873.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00951-3"},{"key":"2025092014531186000_99.12.873.29","unstructured":"Drummond MF . Methods for the economic evaluation of health care programmes. 3rd edn. Oxford: Oxford University Press, 2005."},{"key":"2025092014531186000_99.12.873.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197906143002402"},{"key":"2025092014531186000_99.12.873.31","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-006-0439-3"},{"key":"2025092014531186000_99.12.873.32","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-12-29"},{"key":"2025092014531186000_99.12.873.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2008.03.010"},{"key":"2025092014531186000_99.12.873.34","first-page":"iii","article-title":"Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction","volume":"8","author":"Mowatt","year":"2004","journal-title":"Health Techno Assess"},{"key":"2025092014531186000_99.12.873.35","unstructured":"NICE. Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. London: National Institute for Health and Clinical Excellence, 2003."},{"key":"2025092014531186000_99.12.873.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.01.072"},{"key":"2025092014531186000_99.12.873.37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2010.00762.x"},{"key":"2025092014531186000_99.12.873.38","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2533090507"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2013-303624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:53:19Z","timestamp":1758405199000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2013-303624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,16]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,5,13]]},"published-print":{"date-parts":[[2013,6,15]]}},"alternative-id":["10.1136\/heartjnl-2013-303624"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2013-303624","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,16]]}}}